CoChat

MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer

The DOI matches its Crossref record; 73 of the 74 references it cites were found in a registry or an index.

Abstract

In microorganisms, evolutionarily conserved mechanisms facilitate adaptation to harsh conditions through stress-induced mutagenesis (SIM). Analogous processes may underpin progression and therapeutic failure in human cancer. We describe SIM in multiple in vitro and in vivo models of human cancers under nongenotoxic drug selection, paradoxically enhancing adaptation at a competing intrinsic fitness cost. A genome-wide approach identified the mechanistic target of rapamycin (MTOR) as a stress-sensing rheostat mediating SIM across multiple cancer types and conditions. These observations are consistent with a two-phase model for drug resistance, in which an initially rapid expansion of genetic diversity is counterbalanced by an intrinsic fitness penalty, subsequently normalizing to complete adaptation under the new conditions. This model suggests synthetic lethal strategies to minimize resistance to anticancer therapy.

Overview

Integrity signals

Registry

Crossref · 10.1126/science.aau8768

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 73 references

Research works printed but not linked: 1

  1. 10.1038/nm.3841 · DOI · Paper page

Cited by

See all 104

Metadata

Authors
Cipponi, A., Goode, D. L., Bedo, J., McCabe, M. J., Pajic, M., Croucher, D. R., Rajal, A. G., Junankar, S. R., Saunders, D. N., Lobachevsky, P., Papenfuss, A. T., Nessem, D., Nobis, M., Warren, S. C., Timpson, P., Cowley, M., Vargas, A. C., Qiu, M. R., Generali, D. G., Keerthikumar, S., Nguyen, U., Corcoran, N. M., Long, G. V., Blay, J.-Y., & Thomas, D. M.
Affiliations
  • Garvan Institute of Medical Research (AU)
  • The University of Melbourne (AU)
  • Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
  • UNSW Sydney (AU)
  • Peter MacCallum Cancer Centre (AU)
  • Douglass Hanly Moir Pathology (AU)
  • University of Trieste (IT)
  • The Royal Melbourne Hospital (AU)
  • The University of Sydney (AU)
  • Centre Léon Bérard (FR)
Corresponding author
  • Cipponi, Arcadi
  • Thomas, David M.
Venue
Science
Published
2020-06-05
Volume
368
Issue
6495
Pages
1127-1131
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3033942938
Cited by
103
References
74
Citations by year
2026: 7 · 2025: 11 · 2024: 15 · 2023: 22 · 2022: 16 · 2021: 23 · 2020: 8
FWCI
5.60
Type
journal article
Language
en
Open access
closed
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
Funders
  • Cancer Australia (1143699)
  • Australian national health and medical research council (APP1088353, APP1162860)
  • Girgenshon Foundation
  • MEDnoTE Spin-Off University of Trieste (N/A)
  • Australian national health and medical resesrach council (APP1162556)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
stress-induced mutagenesis, mTOR signaling, drug resistance, synthetic lethality, genome-wide screen, tumor evolution
MeSH terms
Adaptation, Physiological, Antineoplastic Agents, DNA Repair, Humans, Neoplasms, Selection, Genetic, Signal Transduction, Mutagenesis, Drug Resistance, Neoplasm, Cell Line, Tumor, Genome-Wide Association Study, Genetic Fitness, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.